MedPath

TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

SLC13A5 Deficiency Natural History Study - United States Only

Recruiting
Conditions
Citrate Transporter Deficiency
Epilepsy
SLC13A5 Deficiency
EIEE25
Kohlschutter-Tonz Syndrome (non-ROGDI)
Citrate Transporter Disorder
DEE25
Rare Diseases
Movement Disorders
Genetic Disorder
First Posted Date
2023-11-22
Last Posted Date
2024-11-25
Lead Sponsor
TESS Research Foundation
Target Recruit Count
17
Registration Number
NCT06144957
Locations
🇺🇸

Lucille Packard Children's Hospital, Stanford University, Palo Alto, California, United States

🇺🇸

Brown University, Providence, Rhode Island, United States

🇺🇸

University of Texas Southwestern Dallas, Dallas, Texas, United States

SLC13A5 Deficiency Natural History Study - Remote Only

Conditions
Citrate Transporter Deficiency
Epilepsy
Rare Diseases
Movement Disorders
Genetic Disorder
SLC13A5 Deficiency
EIEE25
Kohlschutter-Tonz Syndrome (non-ROGDI)
17p13.1 Deletions Confined to SLC13A5 Gene
Citrate Transporter Disorder
First Posted Date
2020-12-23
Last Posted Date
2024-11-22
Lead Sponsor
TESS Research Foundation
Target Recruit Count
20
Registration Number
NCT04681781
Locations
🇺🇸

Lucille Packard Children's Hospital, Stanford University, Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath